These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 3341652)

  • 1. Drug purpura due to surreptitious quinidine intake.
    Reid DM; Shulman NR
    Ann Intern Med; 1988 Feb; 108(2):206-8. PubMed ID: 3341652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug-dependent and non-drug-dependent antiplatelet antibody in drug-induced immunologic thrombocytopenic purpura.
    Lerner W; Caruso R; Faig D; Karpatkin S
    Blood; 1985 Aug; 66(2):306-11. PubMed ID: 4040409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on quinine- and quinidine-dependent antibodies against platelets and their reaction with platelets in the Bernard-Soulier syndrome.
    van Leeuwen EF; Engelfriet CP; von dem Borne AE
    Br J Haematol; 1982 Aug; 51(4):551-60. PubMed ID: 7049220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoreactions involving platelets. III. Quantitative aspects of platelet agglutination, inhibition of clot retraction, and other reactions caused by the antibody of quinidine purpura.
    SHULMAN NR
    J Exp Med; 1958 May; 107(5):697-710. PubMed ID: 13525580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CHANGE IN PLATELET FACTOR 3 AS A MEANS OF DEMONSTRATING IMMUNE REACTIONS INVOLVING PLATELETS: ITS USE AS A TEST FOR QUINIDINE-INDUCED THROMBOCYTOPENIA.
    HOROWITZ HI; RAPPAPORT HI; YOUNG RC; FUJIMOTO MM
    Transfusion; 1965; 5():336-43. PubMed ID: 14316534
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunoreactions involving platelets. IV. Studies on the pathogenesis of thrombocytopenia in drug purpura using test doses of quinidine in sensitized individuals; their implications in idiopathic thrombocytopenic purpura.
    SHULMAN NR
    J Exp Med; 1958 May; 107(5):711-29. PubMed ID: 13525581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quinidine-induced thrombocytopenic purpura: clinical presentation in relation to drug-dependent and drug-independent platelet antibodies.
    Nieminen U; Kekomäki R
    Br J Haematol; 1992 Jan; 80(1):77-82. PubMed ID: 1536813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 125 I-anti-immunoglobulin test: a new tool for the detection of drug-allergic platelet antibodies.
    Mueller-Eckhardt C; Schulz G; Dienst C; Mahn I; Mayser B
    Vox Sang; 1978; 34(1):43-5. PubMed ID: 341521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of quinidine-specific antibodies with platelet 125I-labeled staphylococcal protein A test.
    Kekomäki R; Rajamäki A; Myllylä G
    Vox Sang; 1980; 38(1):12-8. PubMed ID: 7376562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study of the factors that cause specific transformation in cultures of lymphocytes from patients with quinine- and quinidine-induced immune thrombocytopenia.
    Hosseinzadeh PK; Firkin BG; Pfueller SL
    J Clin Invest; 1980 Oct; 66(4):638-45. PubMed ID: 6999032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydrochlorothiazide-dependent thrombocytopenia due to IgM antibody.
    Eisner EV; Crowell EB
    JAMA; 1971 Jan; 215(3):480-2. PubMed ID: 5107403
    [No Abstract]   [Full Text] [Related]  

  • 12. Detection of drug-dependent antibodies by the 51Cr platelet lysis test: documentation of immune thrombocytopenia induced by diphenylhydantoin, diazepam, and sulfisoxazole.
    Cimo PL; Pisciotta AV; Desai RG; Pino JL; Aster RH
    Am J Hematol; 1977; 2(1):65-72. PubMed ID: 868869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-antibody-platelet interaction in quinine- and quinidine-induced thrombocytopenia.
    Christie DJ; Aster RH
    J Clin Invest; 1982 Nov; 70(5):989-98. PubMed ID: 6215430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet agglutination by an abnormal plasma factor in thrombocytopenic purpura associated with quinidine ingestion.
    BIGELOW FS; DESFORGES JF
    Am J Med Sci; 1952 Sep; 224(3):274-80. PubMed ID: 14952503
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunoreactions involving platelets. II. Theoretical analysis of the model.
    HILL TL
    J Exp Med; 1958 May; 107(5):691-5. PubMed ID: 13525579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoreactions involving platelets. I. A steric and kinetic model for formation of a complex from a human antibody, quinidine as a haptene, and platelets; and for fixation of complement by the complex.
    SHULMAN NR
    J Exp Med; 1958 May; 107(5):665-90. PubMed ID: 13525578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-drug-related antibodies in nonthrombocytopenic cardiac patients.
    Okuno T; Crockatt D
    Am J Clin Pathol; 1976 Apr; 65(4):523-7. PubMed ID: 944527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid diagnosis of drug-induced thrombocytopenic purpura. Report of three cases due to quinine, quinidine, and Dilantin.
    WEINTRAUB RM; PECHET L; ALEXANDER B
    JAMA; 1962 May; 180():528-32. PubMed ID: 14005786
    [No Abstract]   [Full Text] [Related]  

  • 19. Structural features of the quinidine and quinine molecules necessary for binding of drug-induced antibodies to human platelets.
    Christie DJ; Weber RW; Mullen PC; Cook JM; Aster RH
    J Lab Clin Med; 1984 Nov; 104(5):730-40. PubMed ID: 6491470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombocytopenic purpura secondary to quinidine hypersensitivity.
    Salman SJ; Salman L; Salman RA
    Oral Surg Oral Med Oral Pathol; 1977 Jul; 44(1):45-8. PubMed ID: 301998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.